We are excited to announce that Glatect® is now accessible through the MyRx Care™ platform, as part of the Ally Support Program. Patients and Health Care providers can now register their patients directly into the program online.  This collaboration is designed to enhance the affordability and accessibility of Glatect for eligible patients seeking treatment.

Blair Rutledge, President of MyRx Care, expressed enthusiasm for the partnership: "Expanding our collaboration with Pendopharm to include Glatect in our patient support program is a significant step forward. This initiative reflects our unwavering commitment to ensuring patients have access to vital medications while alleviating the financial challenges often associated with healthcare."

For more information about Glatect and the patient support program available through MyRx Care, please visit MyRx Care.

About MyRx Care:

MyRx Care is a patient financial assistance program recognized for its innovative approach to supporting patients in accessing their medications. Through partnerships with pharmaceutical companies and healthcare providers, MyRx Care aims to alleviate the financial burden of healthcare costs for patients across Canada. 

For more information, visit https://about.myrx.care . Or contact us directly at [email protected].